Rutie Yin

机构：Sichuan University, West China Second University Hospital of Sichuan University · ORCID：0000-0002-9221-6727

发表论文 244 篇 · 总被引 2843 次 · h-index 24

代表论文

• Bispecific antibodies: unleashing a new era in oncology treatment (2025 · Molecular Cancer · 被引 35)
• Antibody-drug conjugates in cancer therapy: current advances and prospects for breakthroughs (2025 · Frontiers in Cell and Developmental Biology · 被引 17)
• Immunotherapy in gestational trophoblastic neoplasia: advances and future directions (2025 · Frontiers in Immunology · 被引 10)
• AKT inhibitors in gynecologic oncology: past, present and future (2025 · Frontiers in Oncology · 被引 6)
• GLOBAL PHASE II STUDY OF RISOVALISIB, A SELECTIVE PI3Kα INHIBITOR, AS MONOTHERAPY IN PATIENTS WITH RECURRENT/PERSISTENT OVARIAN CLEAR CELL CARCINOMA HARBORING PIK3CA HOTSPOT MUTATIONS (2025 · International Journal of Gynecological Cancer · 被引 5)
• Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial (2025 · CA A Cancer Journal for Clinicians · 被引 3)